| Literature DB >> 21277409 |
Natasa Strbo1, Monica Vaccari, Savita Pahwa, Michael A Kolber, Eva Fisher, Louis Gonzalez, Melvin N Doster, Anna Hryniewicz, Barbara K Felber, George N Pavlakis, Genoveffa Franchini, Eckhard R Podack.
Abstract
The ER-resident chaperone gp96, when released by cell lysis, induces an immunogenic chemokine signature and causes innate immune activation of DC and NK cells. Here we show that intraperitoneal immunization with a genetically engineered, secreted form of gp96, gp96-Ig chaperoning SIV antigens, induces high levels of antigen specific CD8 CTL in the rectal and vaginal mucosa of Rhesus macaques. The frequency of SIV Gag- and SIV Tat-tetramer positive CD8 CTL in the intestinal mucosa reached 30-50% after the third immunization. Tetramer positive CD8 CTL expressed appropriate functional (granzyme B) and migration markers (CD103). The polyepitope specificity of the mucosal CD8 and CD4 response is evident from a strong, multifunctional cytokine response upon stimulation with peptides covering the gag, tat and env proteins. Induction of powerful mucosal effector CD8 CTL responses by cell-based gp96(SIV)-Ig immunization may provide a pathway to the development of safe and effective SIV/HIV vaccines.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21277409 PMCID: PMC3065331 DOI: 10.1016/j.vaccine.2011.01.044
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641